(Q39379156)

11 September 2017

1 reference

title

Selection of optimal drug therapy for the patient with angina pectoris (English)

1 reference

11 September 2017

C Shub

1

1 reference

11 September 2017

R E Vlietstra

series ordinal

2

1 reference

11 September 2017

M D McGoon

series ordinal

3

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 August 1985

1 reference

11 September 2017

1 reference

11 September 2017

volume

60

1 reference

11 September 2017

issue

8

1 reference

11 September 2017

page(s)

539-548

1 reference

Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

EVALUATION OF "CORONARY VASODILATORS" BY CORONARY ARTERIOGRAPHY

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

The effects of nitroglycerin and amyl nitrite on arteriolar and venous tone in the human forearm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Some effects of nitroglycerin upon the splanchinic, pulmonary, and systemic circulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Drugs and the heart. II. Nitrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Effects of nitroglycerin on the major determinants of myocardial oxygen consumption. An angiographic and hemodynamic assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Effect of nitroglycerin on exercise-induced abnormalities of left ventricular regional function and ejection fraction in coronary artery disease. Assessment by radionuclide clineagiography in symptomatic and asymptomatic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Antianginal effects of nitroglycerin patches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth Muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Adrenergic beta receptor blockade: Hemodynamic importance of intrinsic sympathomimetic activity at rest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

The clinical importance of cardioselectivity and lipophilicity in beta blockers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Dose response effectiveness of propranolol for the treatment of angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

The effects of calcium channel blocking agents on cardiovascular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Randomized, placebo-controlled study of the effect of verapamil on exercise hemodynamics in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Divergent effects of diltiazem in patients with exertional angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Safety and efficacy of diltiazem hydrochloride for the treatment of stable angina pectoris: report of a cooperative clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Treatment of angina pectoris with nifedipine: importance of dose titration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Reduced verapamil clearance during long-term oral administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

The pharmacokinetics of diltiazem in healthy American men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Improved exercise performance in persons with stable angina pectoris receiving diltiazem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Production of ischaemic cardiac pain by nifedipine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Coronary artery syndromes after sudden propranolol withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Effects of Propranolol and Nitroglycerin on Left Ventricular Performance in Patients with Coronary Arterial Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Cardiovascular hemodynamics of bicycle and handgrip exercise in normal subjects before and after administration of propranolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Nifedipine and propranolol: a beneficial drug interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Effect of verapamil on normal sinoatrial node function and on sick sinus syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Hemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Combined therapy with verapamil and propranolol in chronic stable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Nifedipine and beta-blockade as a cause of cardiac failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Effects of verapamil on myocardial performance in coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Electrophysiologic effects of diltiazem hydrochloride on supraventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Pharmacokinetics of diltiazem in severe renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Calcium-Channel Blocking Agents and Asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Effects of cimetidine and ranitidine on hepatic drug metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Hypokalemia from Beta2-Receptor Stimulation by Circulating Epinephrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

The influence of verapamil on serum digoxin concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Digoxin plasma concentrations and nifedipine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

Cigarette smoking and the treatment of angina with propranolol, atenolol, and nifedipine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960573-4

10.1016/S0025-6196(12)60573-4

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference